← Browse by Condition
Medical Condition
gastric adenocarcinoma
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 2, Phase 1, EARLY_Phase 1
NCT06340711 Phase 2
Recruiting
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Enrollment
27 pts
Location
United States
Sponsor
Weill Medical College of Corne...
NCT06808971 Phase 2
Recruiting
Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ
Enrollment
61 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT07284186 Phase 1
Recruiting
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
NCT05804331
Recruiting
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Enrollment
500 pts
Location
Australia
Sponsor
Western Sydney Local Health Di...
NCT07034742 EARLY_Phase 1
Recruiting
Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer
Enrollment
136 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT06059495 Phase 2
Recruiting
Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study
Enrollment
59 pts
Location
France
Sponsor
GERCOR - Multidisciplinary Onc...
NCT06496789 Phase 2
Recruiting
Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer
Enrollment
35 pts
Location
China
Sponsor
Tianjin Medical University Can...
NCT06289374
Recruiting
Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery
Enrollment
100 pts
Location
United Kingdom
Sponsor
Imperial College London
NCT05482516 Phase 3
Recruiting
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Enrollment
20 pts
Location
United States
Sponsor
Georgetown University